Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [18F]DASA-23, a non-invasive probe of pyruvate kinase M2 (PKM2) expression. med./bio.

Published in: Neoplasia 2021; 23 (1): 58-67

Exposure